Citius Oncology/$CTOR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Citius Oncology

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Ticker

$CTOR
Trading on

Industry

Biotechnology

Employees

-

ISIN

US17331Y1091

Citius Oncology Metrics

BasicAdvanced
$75M
-
-$0.37
-0.06
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CTOR

Sign up or log in to buy
Capital at risk
Market closedLow-cap

Upcoming events

No upcoming events
FAQs

Can we use optional cookies? View our Cookie Policy for details.

pixel